Skip to content

A Study on a Healthy Food Supplement Containing Good Bacteria to Improve Gut Health and Control Blood Sugar in People with Type 2 Diabetes

Development and Evaluation of a Probiotic-Enriched Prebiotic Supplement on Gut Microbiota in Individuals with Type 2 Diabetes Mellitus - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091085
Enrollment
52
Registered
2025-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Probiotic enriched Prebiotic supplement: Duration of the supplement: 15 weeks. Developed product needed to be consumed by study participants for the entire study duration of 15 weeks wi

Sponsors

Sri Ramachandra Institute of Higher Education and Research NPV Ramaswamy Udayar Fellowship
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects will be included based on the following criteria: The study participants include people above 18 years with uncontrolled Type 2 diabetes has HbA1c (10-14%), and CBG (250-400mg/dl). Willing to participate in the study, who are getting treatment at Sri Ramachandra Medical Centre and SRH.

Exclusion criteria

Exclusion criteria: To exclude gestational and other diabetes types (maturity-onset diabetes of the young (MODY), type 1 diabetes, and Latent Autoimmune Diabetes in Adults (LADA). To exclude subjects with any chronic illness and immunocompromised state (Chronic Kidney Disease, Chronic Liver Disease, oncological condition, and AIDS). People who are allergic to the prescribed product. On antibiotic supplements and steroid treatment.

Design outcomes

Primary

MeasureTime frame
OUTCOME PARAMETERS: HbA1c, CBG, FBS, PPBS- Baseline, midline, and endline supplementation. HOMA IR- Baseline, midline, and endline supplementation. C-REACTIVE PROTEIN- Baseline, midline, and endline supplementation.Timepoint: Baseline (0 week): HbA1c, CBG, FBS, PPBS, HOMA IR, C-REACTIVE PROTEIN Midline (8th week): CBG, FBS, PPBS, HOMA IR, C-REACTIVE PROTEIN Endline (15th week): CBG, FBS, PPBS, HOMA IR, C-REACTIVE PROTEIN

Secondary

MeasureTime frame
Fecal DNA extraction: The gut microbiota is commonly measured through the fecal DNA extraction method. The fecal DNA extraction method will be measured to the randomly selected group after supplementation. Fecal sample collection After 15 weeks of supplementation, the fecal samples of randomly selected 5 individuals from each experimental & control group will be collected for DNA extraction experiments. The fecal samples will be collected within 3-4 hours in sterile containers, will be promptly transported to the laboratory, & stored at a suitable temperature until DNA extraction for further analysis. Timepoint: Endline 15th week

Countries

India

Contacts

Public ContactDr N Preetha

Sri Ramachandra Institute of Higher Education and Research

preetha.n@sriramachandra.edu.in9840980947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026